Entry into the laparoscopic surgery support robot business through the acquisition of A-Traction
First written in FY2021-Q3. 5 of 11 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「We are also incorporating the assembly and manufacturing of robot bodies into the Devices business and establishing a sales expansion structure, contributing to the development of new fields.」
For ANSUR, in addition to developing tool units, we incorporated the assembly and manufacturing of robot bodies into the Devices business and established a structure for expanding sales. - FY2025WorsenedAnnual report
「With respect to goodwill and other intangible assets related to the 4 companies 朝日サージカルロボティクス株式会社, Pathways Medical Corporation, Rev1. Engineering, Inc. and Asahi Medical Technologies, Inc., the company recognized impairment losses because, after taking into account the recent business environment and future business plans, it was no longer expected to recover its investment due to declining profitability and other factors.」
Recognized an impairment loss of ¥1,992 million on acquisition-related assets of 朝日サージカルロボティクス, which develops ANSUR, due to lower expected recoverability. - FY2025-H1Updated the decline in robotics-related components during the interim period.Annual report
「For medical components, sales declined as transactions involving robotics-related components in the domestic market and components for cardiovascular diagnostic catheters supplied to US companies in overseas markets decreased.」
The company explained that transactions involving domestic robotics-related medical components, which had previously been increasing, declined during the interim consolidated accounting period. - FY2024-Q3AdvancedAnnual report
「As a new initiative, the company delivered 2 units of the surgical assistance robot ANSUR (pronounced “Answer”).」
For ANSUR, the company progressed from delivering the first unit in the previous quarter to delivering 2 units in the domestic market. The robotics business is progressing into the delivery stage. - FY2024-Q2AdvancedAnnual report
「In addition, the company delivered the first unit of the surgical assistance robot ANSUR (pronounced “Answer”).」
Delivered the first unit of ANSUR, a surgical assistance robot developed by 朝日サージカルロボティクス株式会社, advancing the robotics business from the development stage to the delivery stage. - FY2024-Q1Updated the increase in robotics-related components.Annual report
「For medical components, the domestic market saw increases in components related to robotics and endoscopy,」
The domestic market showed an increase in robotics-related components, and the disclosure described an expansion in component transactions related to the robotics business following the acquisition of A-Traction. - FY2023AdvancedAnnual report
「In addition, the company designed components within the tool unit (surgical forceps) of ANSUR, a collaborative assistant robot developed by 朝日サージカルロボティクス株式会社, and also completed assembly of the tool unit itself, contributing to the development of a new business area.」
In the robotics business following the acquisition of A-Traction, completed the design of components for ANSUR’s tool unit and assembly of the unit. - FY2022-Q3Added the percentage interest acquired.Annual report
「Acquired an 85.3% interest in A-Traction (renamed 朝日サージカルロボティクス株式会社 on 1 August 2021) during the first quarter of the fiscal year.」
The disclosure states that an 85.3% interest in A-Traction was acquired during the first quarter. - FY2022-Q2AdvancedAnnual report
「Opened the Tokyo Training Center to provide training in the operation of the next-generation surgical assistance robot ANSUR, developed by 朝日サージカルロボティクス株式会社.」
In the robotics business following the acquisition of A-Traction, opened the Tokyo Training Center to provide training in the operation of the next-generation surgical assistance robot ANSUR. - FY2021AchievedAnnual report
「At a Board of Directors meeting held on 11 March 2021, the company resolved to acquire shares in A-Traction and make it a subsidiary, and acquired all shares on 1 July 2021.」
Completed the acquisition of all shares in A-Traction and made it a wholly owned subsidiary on 1 July 2021. The company is advancing its entry into the laparoscopic surgery assistance robot business to the implementation stage. - FY2021-Q3First statedAnnual report
「At a Board of Directors meeting held on 11 March 2021, the company resolved to acquire all shares of A-Traction and make it a 100%-owned consolidated subsidiary, with the scheduled execution date of the share transfer being 1 July 2021. On the same day, it entered into a share and other equity transfer agreement.」
Resolved to acquire all shares of A-Traction, which develops laparoscopic surgery assistance robots, and make it a wholly owned subsidiary. The company’s own wires will be used as drive wires for the robot hand. For the time being, A-Traction is expected to develop, manufacture and sell the robots, while the group will directly supply consumables. The consideration consists of an upfront payment of ¥2,680 million, with potential milestone payments of up to ¥860 million by December 2023.